Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Health X Platform LtdQ4 FY26Healthcare Services
Home/Stocks/Health X Platform Ltd/Q4 FY26

Health X Platform Ltd Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹296P/E: 508.6Market Cap: ₹977 CrSector: Healthcare Services

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

  • →Health X Platform targets ₹6,000 crore revenue by FY30, with ₹4,000 crore from B2B Retailer Shakti and ₹2,000 crore from B2C Sasta Sundar (Page 3).
  • →Retailer Shakti aims for around ₹1,700 crore revenue in FY27, with Q1 FY27 expected at ₹400 crore—the best in company history (Pages 12-13).
  • →Warehousing expansions from 2.5 lakh to over 8 lakh square feet planned by FY27 to support growth (Page 13).
  • →Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10).
  • →JITO private-label margins expected at 30–40% with initial market response better than expected (Page 11).
  • →Overall, company sees non-linear quarter-to-quarter growth due to experimental startup-phase approach (Page 14).
  • →EBITDA margin target ~5% at ₹6,000 crore revenue scale, with PAT around 4% of revenue (Page 11).

Margin guidance

  • →FY27 and FY28 ROE expected to be low/negative due to initial investments and losses.
  • →By FY29, anticipated profit margin of ~3% on revenue (~₹4,500 crore), translating to ~₹120 crore in profits.
  • →Capital deployed in FY29 expected to be ₹300–400 crores, leading to high ROE (~40% targeted at scale).
  • →EBITDA margin target at ₹6,000 crore revenue scale is approximately 5%.
  • →PAT and cash flow expected to be around 4% of revenue at ₹6,000 crore scale.
  • →Quarterly earnings may fluctuate due to experimental and startup nature of the business.
  • →Profitability expected to improve with scale, operating leverage, and expansion of warehouse and AI initiatives.
  • →Contribution-margin positivity seen in Retailer Shakti and Health Buddy businesses; detailed margins to be disclosed from next quarter.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →No explicit mention of new fundraising through debt or equity in the provided transcript.
  • →The company emphasizes capital efficiency and conservative capital deployment, having only deployed ₹259 crores including cost of capital.
  • →They have recapitalized by buying back shares from Mitsubishi Corporation rather than raising fresh capital.
  • →Future growth plans focus on organic expansion, such as new warehouses and AI platform investments, funded through existing resources.
  • →The company mentions possible partnership or exit strategies post-demerger for Microsec Resources but does not specify fundraising.
  • →Overall strategy is to avoid locking shareholder value in slow-moving entities and focus on partnerships or exits rather than fresh capital raise.

Order book

- The transcript does not explicitly mention the current or expected order book or pending orders for Health X Platform Limited. - Focus areas highlighted include: - Expansion of warehousing capacity (additional 1 lakh sq ft by March 2027, and plans to build 4 lakh more sq ft). - Growth targets with revenue expected to reach ₹6,000 crores by FY2030. - Ongoing initiatives like JITO, Retailer Shakti, and HealthBuddy being scaled. - Plans for AI applications and cautious deployment of capital in technology. - The company emphasizes capital efficiency and steady growth rather than immediate large order inflow. - Management highlights a cautious growth approach without aggressive capital deployment, prioritizing sustainable operational expansion. No direct data on orderbook or pending orders is provided in the transcript.

Capex plans

  • →Total planned capex for warehouse expansion is ₹234 crores (Page 11, 10).
  • →Out of ₹234 crores, ₹134 crores planned through bank loans and ₹100 crores from treasury (Page 10).
  • →Additional warehouse capacity of 1 lakh sq. ft. to go live by March FY27; current capacity 2.5 lakh sq. ft. and plans to build 4 lakh sq. ft. more (Page 13).
  • →Further plan to build 5.52 lakh sq. ft. additional warehouse capacity in Udaipur, Lucknow, Patna, Guwahati, Baripur, totaling over 8 lakh sq. ft. warehouse capacity (Page 13).
  • →Investment of ₹150 crores in AI and tech platforms; ₹75 crores already deployed with ₹75 crores more to be invested (Page 5).
  • →The company remains capital-efficient, deploying total capital including cost of capital of only ₹259 crores (Page 3).
  • →Strategic focus on AI application rollout expected in 6 months, scaling cautiously due to market readiness (Page 5, 14).

How does Health X Platform Ltd rank vs peers in Healthcare Services?

Pro feature
1Health X Platform Ltd
2Healthcare Services Company A
Rev 1Mar 2
3Healthcare Services Company B
Rev 2Mar 1
4Healthcare Services Company C
Rev 2Mar 3

See full Healthcare Services sector rankings

How does Health X Platform Ltd rank in Healthcare Services?

Compare Health X Platform Ltd against every Healthcare Services company (Q4 FY26) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Related research

Read the full Q4 FY26 earnings insight — Health X Platform Ltd

Other quarters — Health X Platform Ltd

Q3 FY26Q2 FY26Q4 FY25Q2 FY25Q3 FY24Q2 FY24Q1 FY24

Healthcare Services peers

Apollo Hospitals Enterprise Ltd · Q4 FY26Fortis Health. · Q1 FY27Syngene Intl. · Q4 FY26Dr Lal Pathlabs · Q1 FY27Narayana Hrudaya · Q1 FY27
Health X Platform Ltd full stock analysisHealthcare Services sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Health X Platform Ltd's management said in earlier quarters

  • Q4 FY26 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q4 FY25 earnings call analysis →
  • Q2 FY26 earnings call analysis →

Others in Healthcare Services this season

  • Aster DM Quality (Q3 FY26)

    Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…

  • Chandan Healthcare Ltd (Q3 FY26)

    The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…

  • Apollo Hospitals Enterprise Ltd (Q4 FY26)

    30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…

  • Rainbow Childrens Medicare Ltd (Q1 FY27)

    Volume growth supported by planned addition of 2,500 beds over 5 years (~15% CAGR) (Page 10). Key concall takeaways from Rainbow Childrens Medicare Ltd's Q1…

Compare:vs Apollo Hospitals Enterprise Ltdvs Max Healthcarevs Fortis Health.